Percutaneous Cryoablation for the Management of Bone and Soft Tissue Tumors

Image-guided percutaneous cryoablation plays an increasingly important role in managing bone and soft tissue tumors. Well-established indications include the treatment of osteoid osteoma, palliation of painful skeletal metastases, and local control of oligometastatic disease. Emerging indications are now a variety of painful benign bone tumors beyond osteoid osteoma, symptomatic soft tissue lesions (such as desmoid fibromatosis, vascular anomalies, abdominal wall endometriosis), as well as local recurrences of bone and soft tissue sarcoma. This state-of-the-art review describes the percutaneous cryoablation technique including current strategies to prevent complications. We also discuss the expanding range of clinical indications, as well as future directions of this promising technology in the musculoskeletal system.

Authors

Institutions

Publication Details

Journal
Seminars in Musculoskeletal Radiology
Published
2026-02-01
DOI
https://doi.org/10.1055/a-2744-8457
Primary Topic
Bone Tumor Diagnosis and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Percutaneous Cryoablation for the Management of Bone and Soft Tissue Tumors

Francesco Arrigoni, Thomas Le Corroller, Daphné Guenoun, Alexandre Rochwerger et al.
Seminars in Musculoskeletal Radiology
Bone Tumor Diagnosis and Treatments
article

Percutaneous Cryoablation for the Management of Bone and Soft Tissue Tumors

Francesco Arrigoni, Thomas Le Corroller, Daphné Guenoun, Alexandre Rochwerger, Pierre Champsaur, Jean-Camille Mattei
article en

Abstract

Image-guided percutaneous cryoablation plays an increasingly important role in managing bone and soft tissue tumors. Well-established indications include the treatment of osteoid osteoma, palliation of painful skeletal metastases, and local control of oligometastatic disease. Emerging indications are now a variety of painful benign bone tumors beyond osteoid osteoma, symptomatic soft tissue lesions (such as desmoid fibromatosis, vascular anomalies, abdominal wall endometriosis), as well as local recurrences of bone and soft tissue sarcoma. This state-of-the-art review describes the percutaneous cryoablation technique including current strategies to prevent complications. We also discuss the expanding range of clinical indications, as well as future directions of this promising technology in the musculoskeletal system.

Seminars in Musculoskeletal RadiologyVol. 30(01)
Centre National de la Recherche Scientifique (FR), Aix-Marseille Université (FR), University of L'Aquila (IT), Institut des Sciences Moléculaires (FR), Assistance Publique Hôpitaux de Marseille (FR), Hôpital Nord (FR)
Openalex Percentile: Top 50%
Bone Tumor Diagnosis and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Percutaneous Cryoablation for the Management of Bone and Soft Tissue Tumors — Francesco Arrigoni, Thomas Le Corroller, et al. · Seminars in Musculoskeletal Radiology (2026) | TGRS Research Map | TGRS